TDAC - NASDAQ
Translational Development Acquisition Corp.
$10.74
-0.19%Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
At a Glance
Live SnapshotTranslational Development Acquisition Corp. Management Team
Mr. Michael M. B. Hoffman J.D.
Chairman of the Board & Chief Executive Officer
Mr. Avi C. Das
Chief Financial Officer
Translational Development Acquisition Corp. Insider Positioning
During the last 12 months, insiders have purchased $614K worth of TDAC shares, with no selling activity reported.
3 Months
53.4K
614.04K
0
0.00
+614K
+$614K
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
0
0.00
0
0.00
+0
+$0
9-12 Months
0
0.00
0
0.00
+0
+$0
Top Buyers
Hoffman Michael B
Director, Officer: Chairman And Ceo
$614K
Top Sellers
No selling activity
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $614K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
Recent Trend (3 Months)
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
Insider Participation
1 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Insider Activity Insight
Unanimous insider buying: Zero selling combined with active buying is rare and typically very bullish. Insiders appear to see significant upside with limited downside risk.
SEC Filings
TDAC - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | January 29, 2026 | January 29, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | February 10, 2025 | February 10, 2025 | 2025 | |
DEF 14A DEF 14A 2023 N/A | November 07, 2023 | November 06, 2023 | 2023 | |
DEF 14A DEF 14A 2023 N/A | June 27, 2023 | June 26, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | April 28, 2022 | June 10, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | May 17, 2021 | May 27, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | November 20, 2020 | November 30, 2020 | 2020 | |
DEF 14A DEF 14A 2020 N/A | August 17, 2020 | August 27, 2020 | 2020 | |
DEF 14A DEF 14A 2020 N/A | May 18, 2020 | May 28, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | November 06, 2019 | November 26, 2019 | 2019 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.